News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|October 31, 2012

Off-label medications common in PICUs

The practice of prescribing medications off label for children is almost the rule for pediatric intensive care units.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Journal Club: Small renal stones can be managed conservatively

Journal Club: Small renal stones can be managed conservatively

ByMarian Freedman,Jon Matthew Farber, MD

June 18th 2026

Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com

Doxecitine/doxribtimine cuts mortality risk in early-onset TK2d, new data show

ByBenjamin P. Saylor

June 17th 2026

Recognizing and managing allergic skin conditions across pediatric populations | Image Credit: © stopabox - stock.adobe.com

Recognizing and managing allergic skin conditions across pediatric populations

ByMike Hennessy Jr, President and CEO

June 17th 2026

$Journal Club: Ultrasound is not reliable for diagnosing ankle fractures$

Journal Club: Ultrasound is not reliable for diagnosing ankle fractures

ByMarian Freedman,Jon Matthew Farber, MD

June 17th 2026

Vosoritide data support planned FDA submission for hypochondroplasia | Image Credit: © Scott Cornell- stock.adobe.com.

Vosoritide data support planned FDA submission for hypochondroplasia

ByMorgan Ebert, Executive Editor

June 16th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Chronicity, Symptom Variability, and Treatment Expectations in Pediatric Functional Constipation and IBS-C

FDA issues Warning Letter to SNOO Smart Sleeper maker over unauthorized sleep sacks, hospital bundle, and quality system failures

Doxecitine/doxribtimine cuts mortality risk in early-onset TK2d, new data show

Vosoritide data support planned FDA submission for hypochondroplasia

Recognizing and managing allergic skin conditions across pediatric populations